Medineering to Present at the 10th Hamlyn Symposium on Medical Robotics

Munich, (PresseBox) - The Munich based surgical robotics startup Medineering announced today that the company will exhibit its new approach for robot assisted minimally invasive surgery from June 25 to 28, 2017 at the Hamlyn Symposium on Medical Robotics.

The company will present the research edition of its Intelligent Positioning Device, which enables research institutes to support their own innovations in robotics – lightweight and compact, highly integrated robots for a variety of surgical accesses, surgical techniques or surgical instruments. Medineering will also show its Endoscope Guidance System* for transnasal endoscopic interventions. Dr. Stephan Nowatschin, CEO and co-founder of Medineering will be available at the booth for discussions on potential collaborations.

Visitors will find the booth in the Symposium’s exhibition area. The 10th Hamlyn Symposium on Medical Robotics will take place at the Hamlyn Center, Imperial College London, South Kensington, London, UK.

Website Promotion

Medineering GmbH

Medineering, headquartered in Munich, develops, manufactures and markets an application-specific and convenient robotic portfolio to make the benefits of robotic assistance available to a broad number of patients. The portfolio consists of the Intelligent Positioning Device and compact application-specific robots assisting surgeons in complex anatomical regions. Dr. Maximilian Krinninger and Dr. Stephan Nowatschin founded Medineering in June 2014. The startup has grown rapidly and the young and international team consists of highly specialized robotic engineers, marketing experts and regulatory specialists.

Diese Pressemitteilungen könnten Sie auch interessieren

News abonnieren

Mit dem Aboservice der PresseBox, erhalten Sie tagesaktuell und zu einer gewünschten Zeit, relevante Presseinformationen aus Themengebieten, die für Sie interessant sind. Für die Zusendung der gewünschten Pressemeldungen, geben Sie bitte Ihre E-Mail-Adresse ein.

Es ist ein Fehler aufgetreten!

Vielen Dank! Sie erhalten in Kürze eine Bestätigungsemail.


Ich möchte die kostenlose Pressemail abonnieren und habe die Bedingungen hierzu gelesen und akzeptiert.